Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
4(100.0%)
4Total
Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05706324Phase 1Unknown

Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine

Role: lead

NCT05718037Phase 1Unknown

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

Role: lead

NCT05672966Phase 1Unknown

Phase I Clinical Trial of a Candidate HPV Vaccine

Role: lead

NCT05602480Phase 1Unknown

Phase I Clinical Trial of a Candidate PCV13 in Healthy People

Role: lead

All 4 trials loaded